Carlyle Insurance Solutions — Annuity & Life Product Tracker
AUM Deployed
$42.8B
▲ +$3.1B QoQ · Across 6 counterparties
Wtd Avg Net Spread
1.74%
▲ +8bps YoY · After fees & reins
Platform ROE
14.2%
▲ vs. 12.8% FY2025 · Economic basis
Pipeline (Next 4Q)
$8.4B
~$5.1B committed · $3.3B probable
Counterparty Exposure
Counterparty
Structure
AUM ($B)
Net Spread
Status
Aegon / Transamerica
Flow Reins
12.4
1.88%
Active
Fortitude Re
Coinsurance
9.7
1.61%
Active
Global Atlantic
Platform M&A
8.2
1.92%
Active
Talcott Resolution
Sidecar
6.1
1.55%
Watch
Aspida Life
Flow Reins
4.8
1.79%
Active
Constellation (New)
Sidecar
1.6
—
Diligence
AUM by Product Line
Net Spread by Counterparty — Quarterly Trend
Peer Spread Benchmark
Apollo / Athene1.91%
Carlyle IS (This Platform)1.74%
KKR / GA1.68%
Blackstone / Resolution1.62%
Brookfield / AEL1.44%
Ares / Aspida1.38%
View A — IS Deployment Dashboard
Internal: How efficiently are we deploying permanent balance sheet capital?
Counterparty:
Assets Deployed
$42.8B
Platform total · Q1 2026
Wtd Crediting Rate (Liability Cost)
4.21%
Book-weighted across all products
Gross Investment Yield
5.95%
New money yield (Q1 2026)
Net Spread Captured
1.74%
After fees, DAC, admin, reins
Asset Deployment Mix — Carlyle Sourced
Carlyle credit & direct lending sourced to insurance platform. IG = investment grade private credit, RE = real estate debt, Infra = infrastructure debt.
Spread Decomposition — Platform Average
Component
Basis Points
% of Gross
Gross Investment Yield
595
100%
— Crediting Rate
(421)
(70.8%)
— DAC Amort
(38)
(6.4%)
— Admin + Overhead
(22)
(3.7%)
— Reinsurance Cost
(40)
(6.7%)
Net Spread (Carlyle)
174
29.2%
Carlyle captures net spread on assets sourced to the platform after paying all liability costs and fee leakage.
Pipeline — Next 4 Quarters
Aegon / Transamerica — FIA Block
Flow reinsurance expansion · Q2 2026 close
$1.8B
Committed
Aspida — MYGA New Business
Co-insurance · Q2-Q3 2026
$900M
Committed
Fortitude Re — Legacy Life Block
ULSG block · modco structure · Q3 2026
$2.4B
Committed
Constellation — Sidecar Launch
New PRT platform · diligence ongoing
$1.5B
Probable
New Counterparty TBD — RILA
Early conversation · Q4 2026 target
$1.8B
Exploratory
Capital Efficiency — Return on Required Capital
Economic ROE on required capital per product type. NAIC RBC C-1+C-3+C-4, plus Carlyle economic capital overlay. Target: >13%.
View B — Insurer Diligence Scorecard
Is this insurer a sound counterparty / acquisition target / sidecar partner?
Target:
Composite Diligence Score — Aegon / Transamerica
Flow Reinsurance Counterparty · FIA / MYGA focus
78 / 100
Weighted composite GREEN — Proceed
Dimension Breakdown
Key Findings & Red Flags
Detailed Scoring Rubric
Dimension
Metric
Actual
Benchmark
RAG
Weight
Notes
Product Intelligence
Crediting mechanics, volume, profitability, persistency, and risk — by product line
Capital Efficiency Comparison — ROE vs. Net Spread
Public Insurers — EDGAR Live Data (FY2025 10-K)
Company
Diligence
Total Assets ($B)
Gen Acct ($B)
Sep Acct %
Gross Yield
Int. Cost
Net Spread
ROE
Leverage
Equity ($B)
AOCI ($B)
Score
Source: SEC EDGAR XBRL. Net spread = (Net Inv. Income – Interest Credited) ÷ Gen Acct Assets. Negative AOCI = unrealized losses from rate environment.
Full Comp Table — Q1 2026
Platform
Insurer Partner
Structure
AUM ($B)
Gross Yield
Liab Cost
Net Spread
ROE
Lead Product
Rating
Carlyle IS
Aegon / Fortitude / GA
Multi-structure
42.8
5.95%
4.21%
1.74%
14.2%
FIA / MYGA
A / A+
Apollo
Athene
Full ownership
280.0
6.22%
4.31%
1.91%
17.1%
MYGA / FIA
A
KKR
Global Atlantic
Full ownership
158.0
5.88%
4.20%
1.68%
15.4%
FIA / RILA
A
Blackstone
Resolution Life
Ownership + Sidecar
95.0
5.75%
4.13%
1.62%
13.8%
VA / UL legacy
A-
Brookfield
American Equity / AEL
Full ownership
65.0
5.44%
4.00%
1.44%
12.1%
FIA
A-
Sixth Street
Talcott Resolution
Ownership + Sidecar
38.0
5.62%
4.07%
1.55%
13.2%
VA in-force
B++
Ares
Aspida Life
Flow Reins
28.0
5.38%
4.00%
1.38%
11.8%
MYGA
A-
Net spread after all liability costs, fees, DAC amortization, and reinsurance ceded. ROE on economic capital. Sources: Public filings, earnings supplements, Carlyle IS estimates.
M&A Target Landscape
Fortitude Re / Carlyle IS — Life & Annuity Acquisition Targets · Confidential
Filter:
High Priority Targets
5
LNC, BHF, Kuvare, Aegon US, Nassau
Total Addressable Assets
~$890B
Across all 20 identified targets
Public Targets (EDGAR Data)
4
LNC · BHF · MET · PRU — live data
Most Actionable
LNC / BHF
Capital pressure · motivated management
Public Targets — Live EDGAR Data (FY 2025 10-K)
Company
Priority
Total Assets ($B)
Sep Acct Assets ($B)
Equity ($B)
Net Inv. Income ($B)
Interest Credited ($B)
Net Spread Est.
Net Income ($B)
Strategic Angle
Lincoln National NYSE: LNC · 10-K Feb 2026
HIGH
417.2
180.1
10.9
6.08
(3.74)
~1.1%
1.18
Capital below 350% RBC. RILA (Level Advantage) strong. VA runoff. Motivated for reins/acquisition.
Brighthouse Financial Nasdaq: BHF · 10-K Feb 2026
HIGH
241.8
85.5
6.8
5.24
(2.19)
~1.2%
0.43
Shield RILA is top-tier product. VA in managed runoff. Clean liabilities (no LTC/ULSG). Acquirable at ~$3.6B mktcap.
MetLife NYSE: MET · 10-K Feb 2026
MEDIUM
745.2
151.9
28.4
22.56
(8.95)
~1.4%
3.38
Reinsurance entities (~$28B) are the target, not the whole company. PRT platform co-invest opportunity.
Prudential Financial NYSE: PRU · 10-K Feb 2026
WATCH
773.7
196.3
32.4
21.47
(5.07)
~1.5%
3.58
PRISMIC (internal Bermuda reins) is the relevant piece. Not a seller — but reinsurance flow agreements possible.
Source: SEC EDGAR XBRL filings. Net spread estimated as (Net Investment Income – Interest Credited) / (Total Assets – Sep Acct Assets). Sep acct assets are policyholder risk — excluded from spread calc.
Public Targets — Investment Income vs. Interest Credited
Estimated Net Spread by Target (bps)
Full Target Universe — All 20 Targets
#
Target
Sponsor / Owner
Category
Products
Ins. Assets ($B)
Capital ($B)
Priority
Strategic Angle
Category 1: Sponsor-backed with US retail + reinsurance. Category 2: Public, not alt-manager owned. Category 3: Reinsurance-only platforms. Assets from Carlyle IS deck (2025Y) and EDGAR for public companies. Private company figures are estimates.
Special Profiles
Deep-dive research — statutory financials, SOTP, and strategic positioning
The $821M gap between statutory income ($41M) and IFRS core earnings ($862M) reflects: IFRS 17 CSM release, different reserve discounting (IFRS = current rates; SAP = locked-in), and LDTI exclusion from core earnings. Statutory is the cash reality; IFRS core is the economic picture. Both show the same structural challenge.
General Fund Invested Assets — $459.9B CAD (Dec 31, 2025)
Asset Class
2025 ($B)
% of Total
2024 ($B)
Change
Cash & short-term
$26.7
6%
$25.8
+$0.9
Fixed Income
Government bonds
$83.4
18%
$83.9
−$0.5
Corporate bonds
$128.4
28%
$125.0
+$3.4
Mortgage ABS
$2.3
1%
$1.8
+$0.5
Private placement debt
$51.8
11%
$49.7
+$2.1
Mortgages
$57.1
12%
$54.4
+$2.7
Bank client loans
$2.7
1%
$2.3
+$0.4
Public equities
$41.0
9%
$33.7
+$7.3
Alternative Long-Duration Assets (ALDA)
Real estate
$12.7
3%
$13.3
−$0.6
Infrastructure
$18.6
4%
$17.8
+$0.8
Timber & agriculture
$6.0
1%
$5.9
flat
Private equity
$18.4
4%
$18.3
flat
Energy
$1.7
—
$1.9
−$0.2
Other ALDA
$4.3
1%
$3.9
+$0.4
Leveraged leases & other
$4.8
1%
$4.8
flat
Total General Fund
$459.9
100%
$442.5
+$17.4
Portfolio Key Metrics
Fixed income total (govt + corp + PP + MBS)
$265.9B (58%)
Mortgages (commercial + residential)
$57.1B (12%)
ALDA total (alternatives)
$65.7B (14%)
Public equities
$41.0B (9%)
Investment income (2025)
$23.9B CAD
Net investment yield (approx)
~5.2%
⚠ AOCI Unrealized Losses (Pre-Tax)
Bond portfolio OCI
−$15.8B
↓ from −$17.5B
Private placements OCI
−$2.7B
↓ from −$3.2B
Mortgages OCI
−$0.9B
↓ from −$1.7B
Total AOCI pressure
−$19.4B
Improving
AOCI improving as rates stabilize. A rate reversal (−100bps) would deepen losses but also reduce liability discount rates — partially self-hedging under IFRS 17.
CSM Analysis — $25.0B Locked-In Future Profit
CSM Metric
2025
2024
Total CSM (incl NCI)
$24,969M
$22,127M
Post-tax CSM (excl NCI)
$22,165M
$19,497M
Organic CSM movement
+$2,257M
—
Organic growth rate
+10%
—
Inorganic CSM movement
+$585M
—
New business CSM
$3,775M
$2,887M
NB CSM growth
+28%
+32%
NB CSM by Segment
2025
Growth
Asia
$1,994M
+27%
Canada
$435M
+22%
U.S. / JH
$396M (US)
+42%
Total NB CSM
$3,775M
+28%
CSM SOTP note: Post-tax CSM of $22.2B at 85% realization = +$11.23/share not captured in P/E-based valuation. This is the key bull case — the locked-in future earnings pipeline.
NBV Performance
2025
Growth
Asia NBV
US$1,832M
+20%
Canada NBV
C$674M
+7%
U.S. NBV
US$214M
+22%
Group total NBV
C$4,837M
+18%
NBV +18% at group level confirms new business quality is strong despite the back-book drag. JH US NBV +22% validates the new protection + RILA franchise.
Capital Structure (Dec 31, 2025 — CAD)
Component
2025
2024
Non-controlling interests
$1,531M
$1,421M
Participating policyholders' equity
$836M
$567M
Preferred shares & other equity
$6,660M
$6,660M
Common shareholders' equity
$43,461M
$44,312M
Total equity
$52,488M
$52,960M
Post-tax CSM
$22,165M
$19,497M
Qualifying capital instruments
$6,990M
$7,532M
Consolidated capital
$81.6B
$79.9B
LICAT ratio — MLI
136%
137%
LICAT ratio — MFC
125%
124%
Excess capital (over 100% MLI)
$24.1B
—
Financial leverage
23.9%
24.0%
Capital Deployment — FY2025
Activity
Amount
Notes
Dividends to shareholders
−C$1.8B
10.2% increase declared
Share buybacks (NCIB)
−C$2.4B
54.4M shares cancelled (3.1%)
Comvest acquisition (WAM)
−C$~1.0B
75% of $17.5B AUM private credit mgr
Capital injection to JHUSA
−US$338M
First injection in 3 years
RGA reinsurance (LTC)
Capital relief
$4.1B liabilities ceded
Sub-debt redemption
−C$1.0B
Net of $0.5B new issuance
Remittances to MFC
+C$6.4B
Strong operating cash generation
Capital allocation read: Manulife returned $5.4B to shareholders in 2025 while injecting capital into a deteriorating JHUSA — a high-confidence signal that management views the JH drag as contained, not systemic. The risk: if JHUSA needs another injection in 2026, the buyback program faces pressure.
✓ Done: Global Atlantic reinsurance transaction (closed Feb 2024)
✓ Done: RGA Canadian reinsurance (closed Apr 2024)
▶ In progress: VA runoff — managed, not sold
◯ Expected: 1–2 more LTC block reinsurances (2026–2027)
Target: LTC+VA contribution <15% of group (achieved: 9% in 2025)
Watch: Each 100bps move in rates drives ~$500M–$1B swing in GAAP net income through MRB marks. Not a capital event — but a recurring headline risk.
Sum-of-Parts Valuation (CAD)
Segment
Earnings
Bear (12–5x)
Base (15–7x)
Bull (18–8x)
Asia
C$2.91B
$35.0B
$43.7B
$52.5B
Global WAM
C$1.93B
$19.3B
$23.2B
$29.0B
Canada
C$1.63B
$16.3B
$19.6B
$21.2B
U.S. / JH
C$1.18B
$5.9B
$8.3B
$9.5B
Corporate
−C$0.22B
−$0.9B
−$1.1B
−$1.1B
Gross SOTP
$75.7B
$93.7B
$111.0B
Holdco disc / Less debt
−$18.3B
−$16.4B
−$15.9B
Equity / Share
$34.18
$46.11
$56.74
vs. current $54.45
−37%
−15%
+4%
+ CSM credit ($22.2B × 85%)
+$9.55
+$9.55
+$9.55
SOTP + CSM / Share
$43.73
$55.66
$66.29
Base + CSM = $55.66/share — essentially in line with current price. Bull + CSM = $66.29. No sell-side SOTP published; all Canadian bank coverage uses blended group P/E.
Analyst Coverage & Price Targets
Analyst
Firm
Rating
Target (CAD)
Date
Darko Mihelic
RBC Capital
BUY
$52
Nov 2025
Mario Mendonca
TD Securities
STRONG BUY
$40
Jun 2024
Tom MacKinnon
BMO Capital
BUY
$35
Feb 2024
John Aiken
Barclays
BUY
$33
Aug 2023
Consensus (15 analysts)
BUY 67%
$54.98
May 2026
67%
Buy / Strong Buy
20%
Hold
13%
Strong Sell
$54.45
Current (52W high)
$54.98
Consensus target
$61.00
High target
⚠ John Hancock Life Insurance Co. (U.S.A.) — Statutory Financial Summary
Source: JHUSA N-VPFS filed April 15, 2026 · NAIC #93628 · Michigan domicile · Auditor: Ernst & Young
Balance Sheet
2025
2024
Total invested assets
$99.8B
$102.5B
Separate accounts
$163.9B
$152.4B
Total admitted assets
$271.6B
$262.1B
Policy reserves
$69.4B
$70.3B
Funds held/coinsurance
$7.1B
$7.7B
AVR
$3.0B
$3.0B
Capital & Surplus
$10.5B
$11.0B
Unassigned surplus
$5.9B
$6.9B
Income Statement
2025
2024
2023
Net premiums
$14.8B
$15.0B
$16.4B
Net investment income
$4.6B
$4.6B
$4.4B
Total revenues
$14.1B
$15.2B
$17.4B
Benefits paid
$19.6B
$19.0B
$18.3B
LTC/disability benefits
$1.1B
$1.0B
$1.1B
Realized cap gains/losses
−$531M
−$487M
−$326M
Statutory Net Income
$41M
$591M
$747M
Capital Waterfall
2025
2024
2023
Opening surplus
$11.0B
$11.4B
$10.8B
Net income
+$41M
+$591M
+$747M
Capital injection
+$338M
—
—
Dividend to parent
−$500M
−$425M
−$500M
Reinsurance & other
−$372M
−$582M
−$221M
Closing surplus
$10.5B
$11.0B
$11.4B
LNC Price (NYSE)
$37.62
−19.7% from 52W high · $7.2B mktcap
Cambial Signal
HOLD
Composite 5.14 · Value 6.85 · Momentum 3.15
Analyst Target
$42.42
+12.7% implied upside · 31% buy rating
M&A Priority
HIGH
RBC below 350% historically · motivated mgmt
Key Financial Metrics (FY2025)
Metric
Value
Comment
Total assets
$417.2B
Incl. $180.1B sep accts
General acct assets
$237.1B
Investable base
Net inv. income
$6.08B
~2.6% yield on gen acct
Interest credited
($3.74B)
Annuity/UL liability cost
Est. net spread
~110bps
vs Carlyle IS target 174bps
Shareholders equity
$10.9B
GAAP book value
Net income (GAAP)
$1.18B
Incl. LDTI noise
Adjusted EPS
~$8.50
~4.4x P/E on adj. basis
Bull / Bear Case
BULL CASE
✓ Value score 6.85 — cheapest in peer group (~4.4x adj. EPS)
✓ Pivot to spread: 66% of annuity sales now non-VA (RILA, FIA, fixed)
✓ Debt tender complete — cleaned 2030–2050 paper
✓ RBC >420% — capital buffer solid
✓ Group Protection record margins (+250bps)
✓ Annuities AUM record $175B
✓ Broker accumulation signal active
✓ Analyst targets rising: $37.67 → $42.42
BEAR CASE
⚠ GAAP net income down 64% YoY — LDTI mark-to-market
⚠ Legacy VA book: $381M MRB loss in Q3 2024
⚠ Net outflows: Retirement Plan Services −$1.0B
⚠ Momentum dead: 3.15 — no price catalyst visible
⚠ Wall St cold: only 31% buy rating (was 36% 3 months ago)
⚠ YTD −19.7% — market not trusting the pivot story
⚠ Legacy ULSG still a reserve overhang
Watch: Q1 2026 earnings (May 2026). If adjusted operating EPS holds $2.00+ and GAAP noise is contained, the story re-rates. Trigger: broker flow sustained 2+ more weeks.
• LDTI earnings volatility — complex for public mkt
CARLYLE IS FIT
• Replace low-yield portfolio with Carlyle credit
• Spread accretion: est. +60-90bps on gen acct
• Estimated Carlyle net spread at Carlyle IS: 174bps
• Group Protection = stable cash flow base
• RILA + FIA = capital-efficient new business
Acquisition at ~$7.2B market cap (current) = ~0.66x book value. In a reinsurance structure, only the spread-bearing general account needs to be acquired — the VA/sep acct liabilities can be ring-fenced or reinsured to a third party (e.g., RGA model). Effective entry price on investable assets could be sub-4%.
Insurance Insight Catalogue
Primer-derived concepts, filing concept search, HTML visuals, and evidence-to-twin architecture.